Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraiya Dubash

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
[<sup>18</sup>F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancerRohini Sharma, Pablo Oriol Valls, Marianna Inglese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudySuraiya Dubash, Tara D Barwick, Kasia Kozlowski, et al.
Journal of the American College of Cardiology|January 25, 2023
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and AtherosclerosisAndrej Ćorović, Christopher Wall, Meritxell Nus, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
[<sup>18</sup>F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancerRohini Sharma, Pablo Oriol Valls, Marianna Inglese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudySuraiya Dubash, Tara D Barwick, Kasia Kozlowski, et al.
Journal of the American College of Cardiology|January 25, 2023
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and AtherosclerosisAndrej Ćorović, Christopher Wall, Meritxell Nus, et al.
Pageof 2